DK1725232T3 - (Indol-3-yl)-heterocykliske derivater som agonister for cannabinoid-CB1-receptoren - Google Patents
(Indol-3-yl)-heterocykliske derivater som agonister for cannabinoid-CB1-receptorenInfo
- Publication number
- DK1725232T3 DK1725232T3 DK05716823T DK05716823T DK1725232T3 DK 1725232 T3 DK1725232 T3 DK 1725232T3 DK 05716823 T DK05716823 T DK 05716823T DK 05716823 T DK05716823 T DK 05716823T DK 1725232 T3 DK1725232 T3 DK 1725232T3
- Authority
- DK
- Denmark
- Prior art keywords
- cannabinoid
- indol
- agonists
- receptor
- heterocyclic derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55056304P | 2004-03-05 | 2004-03-05 | |
| EP04100902 | 2004-03-05 | ||
| EP04103901 | 2004-08-12 | ||
| PCT/EP2005/050833 WO2005089754A1 (en) | 2004-03-05 | 2005-02-28 | (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1725232T3 true DK1725232T3 (da) | 2008-05-26 |
Family
ID=36608981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05716823T DK1725232T3 (da) | 2004-03-05 | 2005-02-28 | (Indol-3-yl)-heterocykliske derivater som agonister for cannabinoid-CB1-receptoren |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7700634B2 (es) |
| EP (1) | EP1725232B1 (es) |
| JP (1) | JP5011097B2 (es) |
| AR (1) | AR048745A1 (es) |
| AT (1) | ATE384525T1 (es) |
| AU (1) | AU2005224041B2 (es) |
| BR (1) | BRPI0508404A (es) |
| CA (1) | CA2557054C (es) |
| DE (1) | DE602005004515T2 (es) |
| DK (1) | DK1725232T3 (es) |
| ES (1) | ES2300995T3 (es) |
| MY (1) | MY139070A (es) |
| NZ (1) | NZ549386A (es) |
| PE (1) | PE20060074A1 (es) |
| PL (1) | PL1725232T3 (es) |
| PT (1) | PT1725232E (es) |
| RS (1) | RS20060502A (es) |
| SI (1) | SI1725232T1 (es) |
| TW (1) | TWI330635B (es) |
| WO (1) | WO2005089754A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI330635B (en) | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
| TW200745096A (en) * | 2005-08-23 | 2007-12-16 | Organon Nv | Indole derivatives |
| US7763732B2 (en) | 2005-08-24 | 2010-07-27 | N.V. Organon | Indole derivatives |
| GB0614062D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| GB0614066D0 (en) * | 2006-07-14 | 2006-08-23 | Glaxo Group Ltd | Compounds |
| TW200848417A (en) * | 2007-02-22 | 2008-12-16 | Organon Nv | Indole derivatives |
| CN109689045A (zh) | 2016-05-04 | 2019-04-26 | 因美制药公司 | 大麻素的局部制剂在治疗大疱性表皮松解症和相关结缔组织病症中的用途 |
| WO2022128050A1 (en) | 2020-12-14 | 2022-06-23 | Symrise Ag | Medicament for fighting inflammation and pain |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ227841A (en) * | 1988-02-12 | 1991-08-27 | Merck Sharp & Dohme | Heterocyclic compounds with at least two non-condensed five membered rings and pharmaceutical compositions |
| US4939138A (en) | 1988-12-29 | 1990-07-03 | Sterling Drug Inc. | 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines |
| AU2001234958A1 (en) * | 2000-02-11 | 2001-08-20 | Bristol-Myers Squibb Company | Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases |
| AUPR118000A0 (en) * | 2000-11-02 | 2000-11-23 | Amrad Operations Pty. Limited | Therapeutic molecules and methods |
| DE60237431D1 (de) | 2001-01-29 | 2010-10-07 | Univ Connecticut | Rezeptor-selektive cannabimimetische aminoalkylindole |
| TW200402417A (en) | 2002-06-21 | 2004-02-16 | Akzo Nobel Nv | 1-[(Indol-3-yl)carbonyl]piperazine derivatives |
| US7772227B2 (en) | 2003-12-17 | 2010-08-10 | N.V. Organon | Tricyclic 1-[(indol-3-yl)carbonyl]piperazine derivatives as cannabinoid CB1 receptor agonists |
| TWI330635B (en) | 2004-03-05 | 2010-09-21 | Organon Nv | (indol-3-yl)-heterocycle derivatives |
| TW200745096A (en) | 2005-08-23 | 2007-12-16 | Organon Nv | Indole derivatives |
| US7763732B2 (en) | 2005-08-24 | 2010-07-27 | N.V. Organon | Indole derivatives |
| TW200848417A (en) | 2007-02-22 | 2008-12-16 | Organon Nv | Indole derivatives |
-
2005
- 2005-02-21 TW TW094105061A patent/TWI330635B/zh not_active IP Right Cessation
- 2005-02-28 DK DK05716823T patent/DK1725232T3/da active
- 2005-02-28 SI SI200530186T patent/SI1725232T1/sl unknown
- 2005-02-28 US US10/590,674 patent/US7700634B2/en not_active Expired - Fee Related
- 2005-02-28 AU AU2005224041A patent/AU2005224041B2/en not_active Ceased
- 2005-02-28 DE DE602005004515T patent/DE602005004515T2/de active Active
- 2005-02-28 EP EP05716823A patent/EP1725232B1/en active Active
- 2005-02-28 WO PCT/EP2005/050833 patent/WO2005089754A1/en active IP Right Grant
- 2005-02-28 ES ES05716823T patent/ES2300995T3/es active Active
- 2005-02-28 BR BRPI0508404-0A patent/BRPI0508404A/pt not_active IP Right Cessation
- 2005-02-28 CA CA2557054A patent/CA2557054C/en not_active Expired - Fee Related
- 2005-02-28 AT AT05716823T patent/ATE384525T1/de active
- 2005-02-28 RS RSP-2006/0502A patent/RS20060502A/sr unknown
- 2005-02-28 PL PL05716823T patent/PL1725232T3/pl unknown
- 2005-02-28 JP JP2007501270A patent/JP5011097B2/ja not_active Expired - Fee Related
- 2005-02-28 PT PT05716823T patent/PT1725232E/pt unknown
- 2005-02-28 NZ NZ549386A patent/NZ549386A/en unknown
- 2005-03-02 MY MYPI20050850A patent/MY139070A/en unknown
- 2005-03-04 AR ARP050100825A patent/AR048745A1/es not_active Application Discontinuation
- 2005-03-04 PE PE2005000245A patent/PE20060074A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TWI330635B (en) | 2010-09-21 |
| DE602005004515T2 (de) | 2009-01-29 |
| JP5011097B2 (ja) | 2012-08-29 |
| ES2300995T3 (es) | 2008-06-16 |
| SI1725232T1 (sl) | 2008-06-30 |
| WO2005089754A1 (en) | 2005-09-29 |
| TW200602316A (en) | 2006-01-16 |
| PL1725232T3 (pl) | 2008-07-31 |
| NZ549386A (en) | 2009-12-24 |
| ATE384525T1 (de) | 2008-02-15 |
| AU2005224041A1 (en) | 2005-09-29 |
| BRPI0508404A (pt) | 2007-07-17 |
| AU2005224041B2 (en) | 2011-03-10 |
| PE20060074A1 (es) | 2006-02-18 |
| CA2557054A1 (en) | 2005-09-29 |
| CA2557054C (en) | 2013-02-19 |
| DE602005004515D1 (de) | 2008-03-13 |
| EP1725232B1 (en) | 2008-01-23 |
| PT1725232E (pt) | 2008-03-04 |
| EP1725232A1 (en) | 2006-11-29 |
| RS20060502A (en) | 2008-11-28 |
| AR048745A1 (es) | 2006-05-24 |
| US7700634B2 (en) | 2010-04-20 |
| MY139070A (en) | 2009-08-28 |
| JP2007526281A (ja) | 2007-09-13 |
| US20070142446A1 (en) | 2007-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1863474T3 (da) | Hidtil ukendte thiophenderivater som sphingosin-1-phosphat-1-receptoragonister | |
| CY2017032I2 (el) | Παραγωγα (θειο)καρβαμοϋλ-κυκλοεξανιου ως ανταγωνιστες των υποδοχεων d3/d2 | |
| DK1856110T3 (da) | Oxyindol derivater som 5HT4-receptor agonister | |
| DK1761519T3 (da) | Indolderivater som histaminreceptorantagonister | |
| ATE509927T1 (de) | Indolderivate als s1p1-rezeptor-agonisten | |
| DK1735304T3 (da) | Quinolinoncarboxamidforbindelser som 5-HT4-receptoragonister | |
| ZA200802007B (en) | 1,3-disubstituted indole derivatives for use as PPAR modulators | |
| IL189390A0 (en) | (indol-3-yl)heterocycle derivatives as agonists of the cannabinoid cb1 receptor | |
| DK1833791T3 (da) | 2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister | |
| ATE504559T1 (de) | Arylanilinderivate als agonisten des beta2- adrenergen rezeptors | |
| ATE388937T1 (de) | Agonisten des cannabinoidrezeptors | |
| DK1501826T3 (da) | Substituerede indoler som alpha-1-agonister | |
| NL1030324A1 (nl) | Sulfonylbenzimidazoolderivaten. | |
| ATE549350T1 (de) | Neuropeptid-2-rezeptor-agonisten | |
| NO20084785L (no) | Benzimidazol 5-slfonamidderivater som cannabinoid 1(CB1) reseptorligander | |
| DK1725232T3 (da) | (Indol-3-yl)-heterocykliske derivater som agonister for cannabinoid-CB1-receptoren | |
| DK1899324T3 (da) | Benzimidazolcarboxamid-forbindelser som 5-HT4-receptoragonister | |
| DE602004009796D1 (de) | Imidazolderivate als glutamatrezeptorantagonisten | |
| EP2097410A4 (en) | HETEROYL-PYRAZOLE DERIVATIVES AS CANNABINOID CB1 RECEPTOR ANTAGONISTS | |
| NO20055758D0 (no) | Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister | |
| DK1896460T3 (da) | Benzofuranylderivater som 5-HT6-receptorinhibitorer | |
| IL177571A0 (en) | (indol-3-yl) heterocycle derivatives as agonists of the cannabinoid cb1 receptor | |
| ZA200607095B (en) | (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor | |
| NO20085035L (no) | Svovelinneholdende pyrazolderivater som selektive cannabinoid CB1 reseptorantagonister |